Should preserving contract pharmacy arrangements be a policy priority when the evidence shows that many of these arrangements benefit large pharmacy chains and intermediaries as much—or more—than the patients Congress ultimately intended to help with 340B has created over 30 years ago?
Related Posts
Cloud-Based HPC Is Helping Researchers Move Healthcare Forward
AWS Provides On-Demand HPC Resources for Healthcare Researchers While there are benefits to on-premises clusters, setting up a traditional HPC cluster can take up […]
What early retirement taught me about burnout and purpose [PODCAST]
Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes! Susan Landers shares her heartfelt journey as a neonatologist navigating the […]
Cutting Marketing? Your Healthcare Brand May Not Recover
Trimming your marketing budget might seem like a quick way to cut costs, but it can hurt your healthcare business more than you think—especially during […]